Development of effective new treatments for multiple myeloma

被引：15

作者：

Anderson, KC ^{[1
]}

Pazdur, R

Farrell, AT

机构：

[1] Dana Farber Canc Inst, Div Hematol Neoplasia, Boston, MA 02115 USA

[2] US FDA, Off Oncol Drug Prod, Rockville, MD 20857 USA

[3] US FDA, Div Oncol Drug Prod, Rockville, MD 20857 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 28期

关键词：

D O I：

10.1200/JCO.2005.02.4950

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：7207 / 7211

页数：5

共 13 条

[1]

Aghajanian C, 2002, CLIN CANCER RES, V8, P2505

[2]

Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x

[3] Approval summary for bortezomib for injection in the treatment of multiple myeloma [J].

Bross, PF ;

Kane, R ;

Farrell, AT ;

Abraham, S ;

Benson, K ;

Brower, ME ;

Bradley, S ;

Gobburu, JV ;

Goheer, A ;

Lee, SL ;

Leighton, J ;

Liang, CY ;

Lostritto, RT ;

McGuinn, WD ;

Morse, DE ;

Rahman, A ;

Rosario, LA ;

Verbois, SL ;

Williams, G ;

Wang, YC ;

Pazdur, R .

CLINICAL CANCER RESEARCH, 2004, 10 (12) :3954-3964

[4]

FARRELL AT, 2003, ANTICANCER DRUG DEV

[5]

Hideshima T, 2001, CANCER RES, V61, P3071

[6] Advances in biology of multiple myeloma: clinical applications [J].

Hideshima, T ;

Bergsagel, PL ;

Kuehl, WM ;

Anderson, KC .

BLOOD, 2004, 104 (03) :607-618

[7]

LeBlanc R, 2002, CANCER RES, V62, P4996

[8]

Lightcap ES, 2000, CLIN CHEM, V46, P673

[9] Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies [J].

Orlowski, RZ ;

Stinchcombe, TE ;

Mitchell, BS ;

Shea, TC ;

Baldwin, AS ;

Stahl, S ;

Adams, J ;

Esseltine, DL ;

Elliott, PJ ;

Pien, CS ;

Guerciolini, R ;

Anderson, JK ;

Depcik-Smith, ND ;

Bhagat, R ;

Lehman, MJ ;

Novick, SC ;

O'Connor, OA ;

Soignet, SL .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (22) :4420-4427

[10] A phase 2 study of bortezomib in relapsed, refractory myeloma [J].

Richardson, PG ;

Barlogie, B ;

Berenson, J ;

Singhal, S ;

Jagannath, S ;

Irwin, D ;

Rajkumar, SV ;

Srkalovic, G ;

Alsina, M ;

Alexanian, R ;

Siegel, D ;

Orlowski, RZ ;

Kuter, D ;

Limentani, SA ;

Lee, S ;

Hideshima, T ;

Esseltine, DL ;

Kauffman, M ;

Adams, J ;

Schenkein, DP ;

Anderson, KC .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (26) :2609-2617

← 1 2 →